The American Journal of Medicine: Supplement

1.6(top 20%)

impact factor

44(top 100%)

papers

957(top 50%)

citations

17(top 50%)

h-index

1.8(top 20%)

extended IF

all documents

990

doc citations

31(top 50%)

g-index

Top Articles

#	Title	Journal	Year	Citations
1	The epidemiology of migraine	The American Journal of Medicine: Supplement	2005	115
2	Clinical implications of the immunomodulatory effects of macrolides	The American Journal of Medicine: Supplement	2004	106
3	Metabolic issues and cardiovascular disease in patients with psychiatric disorders	The American Journal of Medicine: Supplement	2005	103
4	Streptococcus pneumoniae and community-acquired pneumonia: A cause for concern	The American Journal of Medicine: Supplement	2004	52
5	The role of anticholinergics in chronic obstructive pulmonary disease	The American Journal of Medicine: Supplement	2004	51
6	Aging, the gastrointestinal tract, and risk of acid-related disease	The American Journal of Medicine: Supplement	2004	50
7	Metabolic syndrome and cardiovascular disease in patients with human immunodeficiency virus	The American Journal of Medicine: Supplement	2005	49
8	Streptococcus pneumoniae: Epidemiology and patterns of resistance	The American Journal of Medicine: Supplement	2004	47
9	Management of acid-related disorders in patients with dysphagia	The American Journal of Medicine: Supplement	2004	27
10	Prevention of nonsteroidal anti-inflammatory drug–associated gastrointestinal symptoms and ulcer complications	The American Journal of Medicine: Supplement	2004	26
11	Immunomodulatory properties of macrolides: Overview and historical perspective	The American Journal of Medicine: Supplement	2004	25
12	Gastroesophageal reflux disease: Could intervention in childhood reduce the risk of later complications?	The American Journal of Medicine: Supplement	2004	23
13	Review of treatment guidelines for community-acquired pneumonia	The American Journal of Medicine: Supplement	2004	21
14	Appropriate strategies for testing and treating Helicobacter pylori in children: When and how?	The American Journal of Medicine: Supplement	2004	21
15	Evaluation of the patient with diabetes mellitus and suspected coronary artery disease	The American Journal of Medicine: Supplement	2005	19
16	Clinical implications of the immunomodulatory effects of macrolides on sinusitis	The American Journal of Medicine: Supplement	2004	18
17	Applying lessons learned in the treatment of diffuse panbronchiolitis to other chronic inflammatory diseases	The American Journal of Medicine: Supplement	2004	17
18	Clinically meaningful outcomes in patients with chronic obstructive pulmonary disease	The American Journal of Medicine: Supplement	2004	17
19	Evaluating the safety and tolerability profile of acute treatments for migraine	The American Journal of Medicine: Supplement	2005	17
20	Cardioprotective effects and gastrointestinal risks of aspirin: Maintaining the delicate balance	The American Journal of Medicine: Supplement	2004	16
21	The pathophysiology of airway dysfunction	The American Journal of Medicine: Supplement	2004	16
22	Endoscopy-negative reflux disease: Concepts and clinical practice	The American Journal of Medicine: Supplement	2004	16
23	Managing gastroesophageal reflux disease for the lifetime of the patient: Evaluating the long-term options	The American Journal of Medicine: Supplement	2004	12
24	Immunomodulatory effects of macrolides: Implications for practicing clinicians	The American Journal of Medicine: Supplement	2004	12
25	Initiating and optimizing acute therapy for migraine: The role of patient-centered stratified care	The American Journal of Medicine: Supplement	2005	12
26	Epidemiology of diabetes mellitus and associated cardiovascular risk factors: Focus on human immunodeficiency virus and psychiatric disorders	The American Journal of Medicine: Supplement	2005	12
27	Overview of newer antimicrobial formulations for overcoming pneumococcal resistance	The American Journal of Medicine: Supplement	2004	11
28	Will eradication of Helicobacter pylori infection influence the risk of gastric cancer?	The American Journal of Medicine: Supplement	2004	10
29	Extraesophageal symptoms: What role for the proton pump inhibitors?	The American Journal of Medicine: Supplement	2004	9
30	Evaluating the triptans	The American Journal of Medicine: Supplement	2005	9
31	Acute bacterial rhinosinusitis: Clinical impact of resistance and susceptibility	The American Journal of Medicine: Supplement	2004	8
32	Barrett esophagus: Will effective treatment prevent the risk of progression to esophageal adenocarcinoma?	The American Journal of Medicine: Supplement	2004	8
33	Measurement and expression of risk: Optimizing decision strategies	The American Journal of Medicine: Supplement	2004	7
34	Chronic obstructive pulmonary disease: Is there a case for early intervention?	The American Journal of Medicine: Supplement	2004	6
35	Interventions to prevent chronic obstructive pulmonary disease exacerbations	The American Journal of Medicine: Supplement	2004	5
36	Therapeutic choices in reflux disease: Defining the criteria for selecting a proton pump inhibitor	The American Journal of Medicine: Supplement	2004	5
37	Lung function improvements with once-daily tiotropium in chronic obstructive pulmonary disease	The American Journal of Medicine: Supplement	2004	5
38	Identifying migraine in primary care settings	The American Journal of Medicine: Supplement	2005	5
39	Treatment of acute bacterial rhinosinusitis caused by antimicrobial-resistant Streptococcus pneumoniae	The American Journal of Medicine: Supplement	2004	1
40	CME-back	The American Journal of Medicine: Supplement	2004	1
41	CME-front	The American Journal of Medicine: Supplement	2004	0
42	Conclusion: How primary care physicians can help their patients with migraine	The American Journal of Medicine: Supplement	2005	0
43	CME information	The American Journal of Medicine: Supplement	2005	0
44	CME section	The American Journal of Medicine: Supplement	2005	0

Scientometrics

Overviews

Citing Bodies

The American Journal of Medicine: Supplement

Top Articles